论文部分内容阅读
目的:分析莫沙必利联合铝碳酸镁治疗胆汁反流性胃炎的临床疗效。方法:将医院的147例病患分为两组,一组为观察组(74例),一组为对照组(73例)。然后对观察组的病人采用莫沙必利(5mg×24片/盒)联合铝碳酸镁(0.5g×24片/盒)治疗,对照组患者采用多潘立酮(10mg×30片/盒)联合铝碳酸镁(0.5g×24片/盒)治疗。等到一段时间后,对比两组患者的康复情况、心理状况、疼痛程度以及满意程度。结果:在经过一段时间的治疗后,通过统计发现观察组病人的病康复率比对照组要高,并且在治疗后,观察组病人的后遗症明显少于对照组,例如胃痛、胃出血等并发症发病率低于对照组,观察组病人对医院的满意程度也明显要高于对照组。结论:莫沙必利联合铝碳酸镁来治疗胆汁反流性胃炎的方法,是一种更为有效的方法,使得病人康复得更快更完全,并且后遗症和并发症少。
Objective: To analyze the clinical efficacy of mosapride combined with magnesium aluminum carbonate in the treatment of bile reflux gastritis. Methods: The hospital of 147 patients were divided into two groups, one for the observation group (74 cases), one for the control group (73 cases). Patients in the observation group were then treated with mosapride (5 mg x 24 tablets / box) in combination with magnesium aluminum carbonate (0.5 g x 24 tablets / box), and patients in the control group were treated with domperidone (10 mg x 30 tablets / box) Magnesium (0.5 g x 24 tablets / box) treatment. After a period of time, the two groups of patients were compared in terms of rehabilitation, psychological status, degree of pain and satisfaction. Results: After a period of treatment, the recovery rate of the observation group was higher than that of the control group after treatment, and the sequelae of the observation group were obviously less than those of the control group after treatment, such as complications of stomach pain and gastric hemorrhage The incidence was lower than that of the control group, and the patients in the observation group were also much more satisfied with the hospital than the control group. Conclusions: The combination of mosapride and magnesium aluminum carbonate for the treatment of bile reflux gastritis is a more effective method to make patients recover faster and more completely with fewer sequelae and complications.